Healthtech Solutions Inc.

About Healthtech Solutions Inc.

Healthtech Solutions, Inc., through its subsidiaries, operates as a life sciences company. It focuses on the development of wound care products for acute and chronic wounds, including AmnioBind, a placental membrane allograft for burns and non-healing wounds, such as diabetic foot ulcers. The company also engages in the development of ultrasound imaging and artificial intelligence-based image analysis software for the applications in treatment of chest and musculoskeletal system. In addition, it is developing software technology that compares a healthy heart rhythm electronic signal with a damaged heart's signal that derives an electronic signal representing the curative waveform. The company was founded in 2018 and is based in Tuckahoe, New York.

HLTT United States

0.36USD0.01 (+2.78%)

• At close Fri Oct 07 2022

Other OTC exchange

Sector: Healthcare

Industry: Health Information Services

Location United States, Tuckahoe

Grade: AFF

9,620,312 USD
MARKET CAP
.
PE
4.061
BETA (5y)
-0.010
EPS

Profits

for 5 years
11,900%
for 3 years
1,665%
for 2 years
260%
for last year
-20%
for this year
0%
Healthtech Solutions Inc.
© 2023 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.